ArticleJournal of imaging2025
A Deep Learning-Based Approach for Explainable Microsatellite Instability Detection in Gastrointestinal Malignancies.
Article in Journal of imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Artificial Intelligence for Molecular Biomarker Identification in Gastrointestinal and Hepatobiliary Cancers.International journal of molecular sciences · 2026Review
- A Method for Workout Video Classification via Explainable and Federated Learning.Bioengineering (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Microsatellite instability represents a key biomarker in gastrointestinal cancers with significant diagnostic and therapeutic implications. Traditional molecular assays for microsatellite instability detection, while effective, are costly, time-consuming, and require specialized infrastructure. In this paper we propose an explainable deep learning-based method for microsatellite instability detection starting from the analysis of histopathological images. We consider a set of convolutional neural network architectures i.e., MobileNet, Inception, VGG16, VGG19, and a Vision Transformer model, and we propose a way to provide a kind of clinical explainability behind the model prediction through (three) Class Activation Mapping techniques. With the aim to further strengthen trustworthiness in predictions, we introduce a set of robustness metrics aimed to quantify the consistency of highlighted discriminative regions across different Class Activation Mapping methods. Experimental results on a real-world dataset demonstrate that VGG16 and VGG19 models achieve the best performance in terms of accuracy; in particular, the VGG16 model obtains an accuracy of 0.926, while the VGG19 one reaches an accuracy equal to 0.917. Furthermore, Class Activation Mapping techniques confirmed that the developed models consistently focus on similar tissue regions, while robustness analysis highlighted high agreement between different Class Activation Mapping techniques. These results indicate that the proposed method not only achieves interesting predictive accuracy but also provides explainable predictions, with the aim to boost the integration of deep learning into real-world clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.